Carton-10mcg.jpg (Carton 10mcg)
Not available*
Buprenorphine Patch, Extended Release
Product Images NDC 50742-375
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 50742-375). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton-15mcg.jpg (Carton 15mcg)
Carton-20mcg.jpg (Carton 20mcg)
Carton-5mcg.jpg (Carton 5mcg)
Carton-7.5mcg.jpg (Carton 7.5mcg)
Fig1.jpg (Fig1)
Fig2.jpg (Fig2)
This text contains information about the concentration of Buprenorphine TDS (Transdermal Delivery System) over time. The concentration is measured in pg/mL (picograms per milliliter). The study was conducted on 36 individuals who were given a 10 mcg/hour Buprenorphine TDS patch for 7 days and repeated this process three times. The concentration values are plotted on a graph over a period of 26 days. The concentration starts at 300 pg/mL and gradually decreases over time. The concentration values at specific time points are not mentioned in the provided text.*
Fig3.jpg (Fig3)
Fig4.jpg (Fig4)
Figa.jpg (Figa)
Not available*
Figb.jpg (Figb)
Figc.jpg (Figc)
Figd.jpg (Figd)
Fige.jpg (Fige)
Figf.jpg (Figf)
Figg.jpg (Figg)
Figh.jpg (Figh)
Figi.jpg (Figi)
Figj.jpg (Figj)
Figk.jpg (Figk)
Not available.*
Figl.jpg (Figl)
Figm.jpg (Figm)
Fign.jpg (Fign)
Figo.jpg (Figo)
Structure.jpg (Structure)
Table1.jpg (Table1)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
